Allergy Partners Appoints William A. McCann, M.D. as Chief Executive Officer

Dr. McCann to Lead the Company’s Next Chapter of Growth and Innovation, Expanding Patient Access to Care and Driving Continued Improvements to Health Outcomes

ASHEVILLE, N.C.--(BUSINESS WIRE)--Allergy Partners (the “Company”), the leading provider of allergy care across the United States, today announced that William A. McCann, M.D. has been appointed Chief Executive Officer. Dr. McCann has been with Allergy Partners for over twenty years, most recently as Chief Medical Officer since 2015. He succeeds David Brown, M.D., Allergy Partners CEO and Founder, and a thought leader in the field of allergy care, who will continue in his role as the physician-elected member of the Allergy Partners Board of Directors and work closely with Dr. McCann to ensure a smooth transition.

Allergy Partners has grown from a single community practice to the nation’s largest and most trusted allergy and asthma network. With more than 200 providers supported by a dedicated team of over 1,000 employees, Allergy Partners now serves over 300,000 patients across the country each year. Backed by a strategic investment from B-FLEXION in 2021, Allergy Partners is at the forefront of clinical excellence in diagnosing and managing allergy symptoms, with an evidence-based and standardized allergy immunotherapy program, a robust clinical research program, a comprehensive program for the diagnosis and management of food allergies, and a centralized program to improve access to biologics and other advanced medications.

“I’m honored to step into this role and grateful for David’s invaluable leadership in the allergy care space over the past four decades,” said Dr. McCann. “This is an exciting moment for our organization with immense opportunities to embrace new tools and technologies that will reimagine care to more effectively serve our patients and communities. Looking ahead, we remain committed to our mission of making Allergy Partners the best possible place to receive allergy and asthma care, and an incredible place to work every single day.”

Dr. McCann joined Allergy Partners as an M.D. in 2002 and was appointed Chief Medical Officer in 2015. In his role as Chief Medical Officer at Allergy Partners, Dr. McCann implemented clinical operations to support the organization’s state-of-the art immunotherapy, biologics, and pharmacy services to ensure that all patients and their families receive the best care, all while continuing to serve his patients. He is Board Certified by the American Board of Allergy & Immunology and a Fellow of both the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma, & Immunology. Dr. McCann received his Doctor of Medicine degree from Georgetown University and his Master of Business Administration (MBA) degree from the Johns Hopkins University Carey Business School.

“David’s legacy and impact in the allergy and asthma space speaks for itself, and we are immensely grateful for his contributions and the dedication to patients that has driven his work here,” said Francis Crispino, Allergy Partners Chairman and Steven Rotman, B-FLEXION representative. “We’re excited for Bill to spearhead this next chapter for Allergy Partners as the organization continues to grow and advance innovative ways to treat patients and improve health outcomes – all with the goal of transforming the treatment paradigm for allergy care.”

“Having worked closely with Bill for many years, I am confident that he is the right choice to continue to build on our strong foundation and all that we have achieved so far,” said Dr. Brown. “Our utmost priority has always been to provide our patients with the best possible care, and I have seen firsthand how Bill brings the highest level of care and compassion to his patients. Further, he is a seasoned executive and clinical operations leader with a true vision for how to take Allergy Partners to the next level.”

About Allergy Partners

Allergy Partners Holdings, LLC, which in December 2021 received a strategic investment from B-FLEXION, is the nation’s largest and most trusted allergy and asthma practice comprising 150 of the best allergists and immunologists in the country. Allergy Partners has been recognized as a leader in the development and delivery of high-quality health care for patients with asthma & allergic disease, with multiple state-of-the-art programs and facilities at the forefront of clinical excellence and technological advancements. Its vast care network of providers works together to promote education, research, and innovation in the field of allergy and asthma care while maintaining its commitment to offering compassionate, patient-centered services to over 300,000 patients annually.
www.allergypartners.com